A new test could help to diagnose memory issues associated with Alzheimer’s disease in as little as three minutes. According to recently published findings the test, called the Fastball EEG test, may ...

Many people believe that being diagnosed with cognitive degenerative diseases like Alzheimer's is just about forgetting things. However, it is not that simple. The Alzheimer's diagnosis comes with not ...

In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Plus, the early symptoms of Alzheimer's disease to look out for A NEW digital Alzheimer’s test could make the “biggest difference” to diagnoses. The test can be performed by patients on their own and ...

More than 1,000 people across the UK with suspected dementia are to be offered a blood test for Alzheimer's disease which it is hoped could revolutionise diagnosis of the disease. The blood test can ...

Scientists discovered that certain blood proteins linked to brain injury and inflammation strongly correlate with early signs of memory and cognitive decline, especially in Hispanic and Latino adults.

The U.S. Food and Drug Administration (FDA) has cleared another blood test designed to help doctors evaluate Alzheimer’s disease and other causes of memory and cognitive decline. The approval marks an ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

A groundbreaking blood test has been FDA-approved for early Alzheimer's detection, offering a less invasive and more accessible alternative to PET scans and spinal taps. This test measures p-Tau217 ...